Pharmahungary Group is an ISO 9001:2015 certified global R&D service provider company  providing preclinical and clinical R&D services since 2001 is looking for customers for our innovative R&D services. 

1. Preclinical R&D services: focusing on but not restricted to cardiovascular, metabolic, renal, inflammation, oncology, and musculoskletal diseases such as infarction, heart failure, arrhythmias, sepsis, diabetes, insulin resistance, hyperlipidemia, atherosclerosis, obesity, uremia, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH), acute pancreatitis,  septic shock,  arrhythmias, chronic arthritis, traumatic neuropathy, allergic contact dermatitis, ulcerative colitis, acute interstitial pneumonitis, Psoriasiform Dermatitis, sarcopenia, Triple Negative Breast Cancer (TNBC), Small Cell Lung Cancer (SCLC) from in vitro to in vivo studies including large animals as well as various ex vivo models and bioinformatics analysis capabilities. Custom designed combined disease animal models are also available. 

2. Clinical R&D services: full management of clinical trials with Medical Devices including In Vitro Diagnostics, ATMPs, Investigator Initiated Trials, and niche trials that need strong  scientific and regulatory consulting, e.g. clinical trials on sensitive patient population.